FRESENIUS SE+CO.KGAA O.N.

FRE XETRA Healthcare & Biotech Germany
36.27
1.20 %

Fresenius SE is a global healthcare group that provides products and services for dialysis, hospitals, and outpatient care.

Price history of FRESENIUS SE+CO.KGAA O.N.
Price history of FRESENIUS SE+CO.KGAA O.N.

Performance & Momentum

6 Months 18.90 %
1 Year 11.26 %
3 Years 43.18 %
5 Years 8.49 %

Strategic Analysis

FRESENIUS SE+CO.KGAA O.N. • 2026

Fresenius SE is an integrated healthcare group focused on recurring care activities, with a strong presence in dialysis, hospital services, and outpatient care. Its positioning is based on the combination of essential and defensive businesses, as well as an ability to capture structural demand linked to aging populations and the treatment of chronic diseases.

Strengths
  • Exposure to recurring, non-cyclical healthcare markets supported by long-term structural demand
  • Operational diversification across dialysis, hospitals, and outpatient care, reducing dependence on a single revenue source
  • Defensive profile of the healthcare sector, attractive in periods of macroeconomic uncertainty
Weaknesses
  • Recent stock market history is fragile, suggesting that investor confidence in the turnaround is still incomplete
  • Complexity of a multi-business healthcare group, with operational and margin challenges that may vary significantly across divisions
Momentum

Momentum appears to be moderate, with near-term performance still constrained despite a significant rebound over a multi-year horizon. The recent trend still shows pressure on the stock, reflecting a cautious market view of the operating trajectory, but the business model retains defensive appeal for a patient investor if fundamentals continue to improve.

Similar stocks to FRESENIUS SE+CO.KGAA O.N.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone